Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: AJNR Am J Neuroradiol. 2017 May 11;38(7):1297–1302. doi: 10.3174/ajnr.A5188

Table 3.

Patient Characteristics

Characteristic # of infusions # of infusions with at least one event % of infusions with at least one event Odds Ratio p/value*

Age
 <70 years 634 67 10.6 Reference 0.9077
 >70 years 37 4 10.8 1.06 (0.37, 3.02)

Race
 white 645 68 10.5 Reference 0.8716
 non-white 26 3 11.5 1.10 (0.35, 3.50)

Gender
 female 272 33 12.1 Reference 0.3817
 male 399 38 9.5 0.79 (0.47, 1.33)

Number of existing allergies 0.0264**
 none 333 25 7.5 Reference
 one or two 268 39 14.6 2.13 (1.23, 3.70) 0.0072***
 >2 allergies 70 7 10 1.35 (0.58, 3.17) 0.4876

Ferumoxytol dose 0.4036**
 ≤ 2mg/kg 121 8 6.6 Reference
 2–4 mg/kg 303 34 11.2 1.77 (0.69, 4.54) 0.2340
 >4 mg/kg 247 29 11.7 1.86 (0.75, 4.58) 0.1787

Steroid use
 None 461 44 9.5 Reference 0.1263
 on decadron 183 25 13.7 1.56 (0.92, 2.67)

Pathology
 Non-tumor 5.4 5 9.3 Reference 0.7069.
 tumor 617 66 10.7 1.20 (0.47, 3.04)
*

P-value are obtained from the logistic generalized estimating equation model.

**

Overall P-value for the number of existing allergies, or Ferumoxytol dose.